BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND U2AF1, ENSG00000160201, 7307, Q01081, U2AFBP, U2AF35, RNU2AF1, RN, FP793, DKFZp313J1712 AND Diagnosis
49 results:

  • 1. The dilemma of radiation necrosis from diagnosis to treatment in the management of brain metastases.
    Mayo ZS; Billena C; Suh JH; Lo SS; Chao ST
    Neuro Oncol; 2024 Mar; 26(12 Suppl 2):S56-S65. PubMed ID: 38437665
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. A radiomics model for predicting the response to methylprednisolone in brain necrosis after radiotherapy for nasopharyngeal carcinoma.
    Zhuo X; Zhao H; Chen M; Mu Y; Li Y; Cai J; Li H; Xu Y; Tang Y
    Radiat Oncol; 2023 Mar; 18(1):43. PubMed ID: 36859353
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. DEGRO practical guideline for central nervous system radiation necrosis part 2: treatment.
    Bernhardt D; König L; Grosu AL; Rieken S; Krieg SM; Wick W; Wiestler B; Schmidt-Graf F; Sahm F; Gempt J; Meyer B; Krause BJ; Petersen C; Fietkau R; Thomas M; Giordano F; Wittig-Sauerwein A; Debus J; Tabatabai G; Hau P; Steinbach J; Combs SE;
    Strahlenther Onkol; 2022 Nov; 198(11):971-980. PubMed ID: 36038670
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. DEGRO practical guideline for central nervous system radiation necrosis part 1: classification and a multistep approach for diagnosis.
    Bernhardt D; König L; Grosu A; Wiestler B; Rieken S; Wick W; Gempt J; Krieg SM; Schmidt-Graf F; Sahm F; Meyer B; Krause BJ; Petersen C; Fietkau R; Thomas M; Giordano F; Wittig-Sauerwein A; Debus J; Tabatabai G; Hau P; Steinbach J; Combs SE;
    Strahlenther Onkol; 2022 Oct; 198(10):873-883. PubMed ID: 36038669
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Diagnostic Accuracy of Centrally Restricted Diffusion Sign in Cerebral Metastatic Disease: Differentiating Radiation Necrosis from Tumor Recurrence.
    Puac-Polanco P; Zakhari N; Miller J; McComiskey D; Thornhill RE; Jansen GH; Nair VJ; Nguyen TB
    Can Assoc Radiol J; 2023 Feb; 74(1):100-109. PubMed ID: 35848632
    [No Abstract]    [Full Text] [Related]  

  • 6. Dynamic
    Lim W; Acker G; Hardt J; Kufeld M; Kluge A; Brenner W; Conti A; Budach V; Vajkoczy P; Senger C; Prasad V
    Cancer Treat Res Commun; 2022; 32():100583. PubMed ID: 35688103
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Machine learning imaging applications in the differentiation of true tumour progression from treatment-related effects in brain tumours: A systematic review and meta-analysis.
    Bhandari A; Marwah R; Smith J; Nguyen D; Bhatti A; Lim CP; Lasocki A
    J Med Imaging Radiat Oncol; 2022 Sep; 66(6):781-797. PubMed ID: 35599360
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Single low-dose targeted bevacizumab infusion in adult patients with steroid-refractory radiation necrosis of the brain: a phase II open-label prospective clinical trial.
    Dashti SR; Kadner RJ; Folley BS; Sheehan JP; Han DY; Kryscio RJ; Carter MB; Shields LBE; Plato BM; La Rocca RV; Spalding AC; Yao TL; Fraser JF
    J Neurosurg; 2022 Dec; 137(6):1676-1686. PubMed ID: 35426830
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Histopathology and surgical outcome of symptomatic treatment-related changes after gamma knife radiosurgery in patients with brain metastases.
    Kim JH; Choi JW; Kong DS; Seol HJ; Nam DH; Ryu JW; Kim ST; Suh YL; Lee JI
    Sci Rep; 2022 Feb; 12(1):3013. PubMed ID: 35194082
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A novel nomogram to predict overall survival in head and neck cancer survivors with radiation-induced brain necrosis.
    Pan D; Rong X; Zhu Y; Ng WT; Chen D; Li H; Xu Y; Tang Y;
    Radiother Oncol; 2022 Mar; 168():121-129. PubMed ID: 35121029
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Salvage Surgical Resection after Linac-Based Stereotactic Radiosurgery for Newly Diagnosed brain Metastasis.
    Matsuda R; Morimoto T; Tamamoto T; Inooka N; Ochi T; Miyasaka T; Hontsu S; Yamaki K; Miura S; Takeshima Y; Tamura K; Yamada S; Nishimura F; Nakagawa I; Motoyama Y; Park YS; Hasegawa M; Nakase H
    Curr Oncol; 2021 Dec; 28(6):5255-5265. PubMed ID: 34940078
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Risk of symptomatic radiation necrosis in patients treated with stereotactic radiosurgery for brain metastases.
    Sayan M; Şahin B; Mustafayev TZ; Kefelioğlu EŞS; Vergalasova I; Gupta A; Balmuk A; Güngör G; Ohri N; Weiner J; Karaarslan E; Özyar E; Atalar B
    Neurocirugia (Astur : Engl Ed); 2021; 32(6):261-267. PubMed ID: 34743823
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Pathological and genomic phenotype of second neuroendocrine carcinoma during long-term follow-up after radical radiotherapy for nasopharyngeal carcinoma.
    Peng YP; Liu QD; Lin YJ; Peng SL; Wang R; Xu XW; Wei W; Zhong GH; Zhou YL; Zhang YQ; Liu Y; Wang SY; Hong HY; Liu ZG
    Radiat Oncol; 2021 Oct; 16(1):198. PubMed ID: 34635145
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Bevacizumab for stereotactic radiosurgery-induced radiation necrosis in patients with non-small cell lung cancer treated with immune check-point inhibitors.
    Moore A; Yust-Katz S; Icht O; Eliyahou R; Gordon N; Cohen AY; Goldstein IM; Peled N; Seigal T; Amiel A; Dudnik E
    J Neurol Sci; 2021 Aug; 427():117556. PubMed ID: 34186494
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The effect of surgery on radiation necrosis in irradiated brain metastases: extent of resection and long-term clinical and radiographic outcomes.
    Newman WC; Goldberg J; Guadix SW; Brown S; Reiner AS; Panageas K; Beal K; Brennan CW; Tabar V; Young RJ; Moss NS
    J Neurooncol; 2021 Jul; 153(3):507-518. PubMed ID: 34146223
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Efficacy of salvage stereotactic radiotherapy (SRT) for locally recurrent brain metastases after initial SRT and characteristics of target population.
    Holub K; Louvel G
    Clin Transl Oncol; 2021 Jul; 23(7):1463-1473. PubMed ID: 33464481
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. brain Metastasis Recurrence Versus Radiation Necrosis: Evaluation and Treatment.
    Lee D; Riestenberg RA; Haskell-Mendoza A; Bloch O
    Neurosurg Clin N Am; 2020 Oct; 31(4):575-587. PubMed ID: 32921353
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. A Liquid Biopsy to Assess brain Tumor Recurrence: Presence of Circulating Mo-MDSC and CD14+ VNN2+ Myeloid Cells as Biomarkers That Distinguish brain Metastasis From Radiation Necrosis Following Stereotactic Radiosurgery.
    Soler DC; Kerstetter-Fogle A; Elder T; Raghavan A; Barnholtz-Sloan JS; Cooper KD; McCormick TS; Sloan AE
    Neurosurgery; 2020 Dec; 88(1):E67-E72. PubMed ID: 32823285
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Identification and Management of Progressive Enhancement After Radiation Therapy for brain Metastases: Results from a Neurosurgical Survey.
    Semonche A; Patel NV; Yang I; Danish SF
    World Neurosurg; 2020 Jul; 139():e526-e540. PubMed ID: 32311550
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A multi-institutional analysis of clinical outcomes and patterns of care of 1p/19q codeleted oligodendrogliomas treated with adjuvant or salvage radiation therapy.
    Lin AJ; Kane LT; Molitoris JK; Smith DR; Dahiya S; Badiyan SN; Wang TJC; Kruser TJ; Huang J
    J Neurooncol; 2020 Jan; 146(1):121-130. PubMed ID: 31741234
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3.